Naor
Rapid Diagnostic Systems specializes in decentralized rapid RNA diagnosis of COVID-19 and other pathogens, with a focus on innovative, scalable, and easy-to-use testing solutions. Their platform, NaorCov19, offers rapid, saliva-based molecular diagnostics that are suitable for various settings including workplaces, airports, schools, and homes. The company emphasizes technological advancement, collaboration with research institutions like the Technion, and aims to make testing accessible and efficient worldwide.
Industries
Nr. of Employees
small (1-50)
Products
Saliva-based rapid molecular diagnostic kit
A kit for decentralized molecular detection of RNA targets using direct saliva sampling, isothermal amplification, and colorimetric readout to provide results on-site within approximately one hour.
Disposable saliva collection device and low-cost incubator
Single-use saliva collection consumable designed for compatibility with the extraction-free assay and paired with inexpensive heating devices for sample incubation.
Cloud-integrated test documentation and reporting system
Digital platform for documenting sample collection, tracking results, and notifying stakeholders via cloud services and SMS.
Saliva-based rapid molecular diagnostic kit
A kit for decentralized molecular detection of RNA targets using direct saliva sampling, isothermal amplification, and colorimetric readout to provide results on-site within approximately one hour.
Disposable saliva collection device and low-cost incubator
Single-use saliva collection consumable designed for compatibility with the extraction-free assay and paired with inexpensive heating devices for sample incubation.
Cloud-integrated test documentation and reporting system
Digital platform for documenting sample collection, tracking results, and notifying stakeholders via cloud services and SMS.
Services
Mass testing deployment and surveillance
On-site implementation of high-throughput, decentralized testing workflows for institutions and transport settings to enable regular surveillance and screening.
Clinical validation and sample testing support
Conducting clinical evaluations and performance studies using biobank and patient-collected samples to assess assay sensitivity and operational characteristics.
Technology partnerships and R&D collaboration
Partnerships with academic labs, medical centers and government R&D organizations for co-development, testing and scale-up of molecular diagnostic assays.
Mass testing deployment and surveillance
On-site implementation of high-throughput, decentralized testing workflows for institutions and transport settings to enable regular surveillance and screening.
Clinical validation and sample testing support
Conducting clinical evaluations and performance studies using biobank and patient-collected samples to assess assay sensitivity and operational characteristics.
Technology partnerships and R&D collaboration
Partnerships with academic labs, medical centers and government R&D organizations for co-development, testing and scale-up of molecular diagnostic assays.
Expertise Areas
- Decentralized molecular diagnostics
- Point-of-care testing and surveillance
- Clinical validation and sample-based performance evaluation
- Isothermal nucleic acid amplification methods
Key Technologies
- RT-LAMP (reverse-transcribed loop-mediated isothermal amplification)
- Colorimetric assay chemistry
- RNA extraction–free protocols
- Saliva-based sampling